Full-Time
Strategic Customer Success Manager
OpenLoop
501-1,000 employees
White-label telehealth platform and services
No salary listed
Remote in USA + 1 more
More locations: Des Moines, IA, USA
Remote
The role can be fully remote or based at the Des Moines headquarters.
Bachelor's
 Customer Experience & Support (1) |
|---|
Get referred to OpenLoop
See people who can refer or advise you
- A Bachelor's degree in Business, Healthcare Administration, or a related field, or equivalent experience.
- 8–12+ years of experience in enterprise Customer Success or Account Management, preferably in B2B SaaS or platform environments.
- Prior Strategic or Principal Customer Success Manager or Strategic Account Director experience with multi-year revenue ownership.
- Experience building a playbook, framework, or standard that scaled beyond individual accounts and improved whole-team performance.
- A strong mental model of complex integrations and application programming interfaces sufficient to guide clients' technical leaders.
- Comfort with multi-year deal architecture, pricing conversations, and expansion strategy.
- Ability to guide complex, multi-program customer engagements from signing onward, including sequencing workstreams, stakeholders, and milestones.
- Ability to build trust with C-suite stakeholders and engage effectively with client chief executive officers.
- Ability to use data to identify trends and build repeatable solutions.
- Own OpenLoop's most strategically consequential enterprise accounts end-to-end, with accountability for retention, multi-year expansion, and long-term partnership.
- Build and own the customer success operating model, including net revenue retention methodology, quarterly business review standards, strategic account-planning frameworks, and health and risk models.
- Identify and execute multi-year expansion and product-diversification opportunities tied to measurable client return on investment.
- Drive adoption and utilization across accounts, including new-site and feature rollouts and reactivation of dormant usage, while orchestrating Implementation and specialist resources.
- Run complex, multi-program customer engagements as executive-level programs by sequencing workstreams, aligning stakeholders, and driving milestones.
- Partner with Sales and Commercial leadership on end-to-end renewals and multi-year expansion architecture, including pricing and value articulation.
- Monitor account health and engagement signals to proactively identify and mitigate concentration risks.
- Synthesize enterprise customer insights to influence product roadmap prioritization.
- Navigate architecture and data-flow decisions with client technical leadership and translate technical complexity into business outcomes.
- Act as a player-coach for the senior Customer Success team by reviewing account plans and quarterly business reviews and improving enterprise delivery quality across the organization.
- Lead executive-level quarterly business reviews that demonstrate return on investment and plan multi-year scale.
- Familiarity with healthcare delivery or clinical operations.
OpenLoop Health provides white-label telehealth infrastructure that lets organizations launch or scale virtual care. Its platform includes a HIPAA-compliant toolkit—electronic health records, scheduling, payments, video visits, and API integrations—plus back-end services like regulatory setup and revenue-cycle management. It relies on a nationwide clinician network across all 50 states to staff and credential care, enabling partners to keep their own brand. Its goal is to make virtual care accessible to organizations of any size by delivering end-to-end virtual care through combined technology, staffing, and operations support.
Company Size
501-1,000
Company Stage
Series A
Total Funding
$26.2M
Headquarters
Des Moines, Iowa
Founded
2020
Get referred to OpenLoop
See people who can refer or advise you
Simplify's Take
What believers are saying
- Launchpad launched June 16, 2026 with five programs and 300-plus partner organizations.
- OpenLoop said June 2026 it supports over 20,000 clinicians and 220,000 monthly visits.
- Season Health and Happy Sleep expand revenue into nutrition and at-home diagnostics.
What critics are saying
- January 7, 2026 breach exposed data on 716,000 people, triggering regulatory scrutiny.
- Morehart v. Openloop Health, filed February 16, 2026, targets class-action damages and monitoring costs.
- Launchpad commoditizes telehealth setup, inviting rivals like Included Health and Wheel to undercut pricing.
What makes OpenLoop unique
- OpenLoop bundles software, clinicians, credentialing, and compliance into one white-label stack.
- June 16, 2026 Launchpad promises branded virtual care in 24 hours across 50 states.
- April 2026 Season Health adds dietitians and food-as-medicine capabilities for chronic care.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Flexible Work Hours
Unlimited Paid Time Off
401(k) Retirement Plan
401(k) Company Match
Flexible Spending/Health Savings Account
Pet Insurance
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↓ -2%Happy Health, an Austin-based digital health company, secured $75 million in Series A funding led by ARCH Venture Partners and OpenLoop to expand its AI-powered home care platform. The startup's FDA-cleared Happy Ring is the first smart ring approved for multi-night sleep testing and continuous biometrics. It diagnoses obstructive sleep apnea and insomnia in as few as three nights with 98% accuracy, according to the company. The platform collects over 2.8 million biometric measurements nightly, building individualised physiological baselines rather than comparing patients to population averages. Happy Sleep includes board-certified sleep physicians and accepts most major insurance plans, including Blue Cross and Medicare. The company plans to extend its continuous monitoring approach to cardiovascular, metabolic, and other chronic diseases.
Opendoor Technologies reported second-quarter results showing revenue of $883 million, down from $1,567 million year-over-year. Net loss widened to $162 million, with loss per share from continuing operations at $0.17. The company noted a 149% year-over-year increase in homes acquired and early traction in its new mortgage product. Management expects at least 20% revenue growth in the third quarter and aims for adjusted net income profitability by year-end 2026. The results highlight tensions in Opendoor's business model, as it attempts to rebuild scale whilst managing inventory and funding risks. Six-month losses totalled $335 million. The company's debt-funded inventory model continues to face scrutiny from investors concerned about liquidity and margins.
Opendoor Technologies has gained over 18% in the past month, driven by strong housing data and improved unit economics. As of Q1 2026, 15 billionaire investors held the stock. The company's inclusion in the Russell 3000 index on 27 May, effective 26 June 2026, also boosted gains. Opendoor posted strong Q1 2026 results on 8 May, with revenue of $720 million topping consensus estimates of $667.16 million. Management reported signing its largest volume of home acquisition contracts since 2022, roughly double the previous quarter. Resale margins improved monthly since September 2025, with March 2026 posting the best contribution margin in nearly two years. Aged inventory dropped from 51% in Q3 2025 to 10%. Management expects to reach adjusted EBITDA breakeven in Q2 2026.
The infrastructure telehealth platform will add Hey Revia's automated voice and patient communication capabilities to its Launchpad telehealth platform.
OpenLoop, an infrastructure telehealth platform, has acquired Hey Revia, an AI communication platform specialising in automated voice and patient communication capabilities. The acquisition will integrate Hey Revia's technology into OpenLoop's Launchpad telehealth platform, enhancing its communication infrastructure for healthcare providers and patients. Financial terms of the deal were not disclosed.